{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:43:35Z","timestamp":1791297815427,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.cca.2019.06.010","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T01:42:17Z","timestamp":1560130937000},"page":"7-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Procalcitonin: Between evidence and critical issues"],"prefix":"10.1016","volume":"496","author":[{"given":"Elena","family":"Aloisio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Dolci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Panteghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.06.010_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2019.06.010_bb0010","unstructured":"The World Sepsis Declaration. www.worldsepsisday.org, accessed on March 9th, 2019."},{"key":"10.1016\/j.cca.2019.06.010_bb0015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"45","author":"Rhodes","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0020","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1373\/clinchem.2004.032144","article-title":"Toward resolving the challenges of sepsis diagnosis","volume":"50","author":"Carrigan","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.06.010_bb0025","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2018.12179","article-title":"Antibiotics for sepsis - finding the equilibrium","volume":"320","author":"Klompas","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2019.06.010_bb0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1515\/CCLM.1999.119","article-title":"Molecular aspects and natural source of procalcitonin","volume":"37","author":"Russwurm","year":"1999","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-8981(02)00101-8","article-title":"Pathobiochemistry and clinical use of procalcitonin","volume":"323","author":"Meisner","year":"2002","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2019.06.010_bb0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(17)31444-7","article-title":"Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns)","volume":"390","author":"Stocker","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2019.06.010_bb0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s001340050543","article-title":"Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome","volume":"24","author":"Mimoz","year":"1998","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/1724600817747518","article-title":"Procalcitonin as a postoperative marker in the follow-up of patients affected by medullary thyroid carcinoma","volume":"33","author":"Trimboli","year":"2018","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.cca.2019.06.010_bb0055","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1097\/00003246-199708000-00024","article-title":"Effect of classic heat stroke on serum procalcitonin","volume":"25","author":"Nylen","year":"1997","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0060","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1373\/clinchem.2004.037275","article-title":"Biological variation of procalcitonin in healthy individuals","volume":"50","author":"Barassi","year":"2004","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.06.010_bb0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/10408363.2016.1150252","article-title":"Generation of data on within-subject biological variation in laboratory medicine: an update","volume":"53","author":"Braga","year":"2016","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.cca.2019.06.010_bb0070","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/eri.10.25","article-title":"Procalcitonin for guidance of antibiotic therapy","volume":"8","author":"Schuetz","year":"2010","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.cca.2019.06.010_bb0075","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1097\/01.CCM.0000226413.54364.36","article-title":"Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis","volume":"34","author":"Uzzan","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.annemergmed.2006.10.020","article-title":"Procalcitonin test in the diagnosis of bacteremia: a meta-analysis","volume":"50","author":"Jones","year":"2007","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0085","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(07)70052-X","article-title":"Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis","volume":"7","author":"Tang","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cca.2019.06.010_bb0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1473-3099(12)70323-7","article-title":"Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis","volume":"13","author":"Wacker","year":"2013","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cca.2019.06.010_bb0095","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.cmi.2014.12.026","article-title":"The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis","volume":"21","author":"Hoeboer","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cca.2019.06.010_bb0100","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.burns.2014.08.019","article-title":"Serum procalcitonin as a diagnostic biomarker for sepsis in burned patients: a meta-analysis","volume":"41","author":"Ren","year":"2015","journal-title":"Burns"},{"key":"10.1016\/j.cca.2019.06.010_bb0105","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1186\/s40064-016-3591-5","article-title":"Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis","volume":"5","author":"Liu","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.cca.2019.06.010_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168475","article-title":"The use of procalcitonin (PCT) for diagnosis of sepsis in burn patients: a meta-analysis","volume":"11","author":"Cabral","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2019.06.010_bb0115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13613-017-0316-z","article-title":"Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis","volume":"7","author":"Wu","year":"2017","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.cca.2019.06.010_bb0120","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1002\/jcb.27870","article-title":"The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: a systematic review and meta-analysis","volume":"120","author":"Tan","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cca.2019.06.010_bb0125","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1373\/clinchem.2017.271544","article-title":"Overinterpretation of research findings: evidence of \"spin\" in systematic reviews of diagnostic accuracy studies","volume":"63","author":"McGrath","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2019.06.010_bb0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00134-011-2174-8","article-title":"Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis","volume":"37","author":"Vouloumanou","year":"2011","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0135","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/514576","article-title":"Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates","volume":"26","author":"Chiesa","year":"1998","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cca.2019.06.010_bb0140","doi-asserted-by":"crossref","first-page":"F283","DOI":"10.1136\/adc.2005.085449","article-title":"Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram","volume":"91","author":"Turner","year":"2006","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"10.1016\/j.cca.2019.06.010_bb0145","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1097\/MD.0000000000001230","article-title":"Early-onset neonatal sepsis: still room for improvement in procalcitonin diagnostic accuracy studies","volume":"94","author":"Chiesa","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2019.06.010_bb0150","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa040845","article-title":"Clinical features and prognostic factors in adults with bacterial meningitis","volume":"351","author":"Van de Beek","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2015.07.011","article-title":"The role of serum procalcitonin in the diagnosis of bacterial meningitis in adults: a systematic review and meta-analysis","volume":"38","author":"Vikse","year":"2015","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cca.2019.06.010_bb0160","doi-asserted-by":"crossref","first-page":"e3079","DOI":"10.1097\/MD.0000000000003079","article-title":"Diagnostic accuracy of procalcitonin in bacterial meningitis versus nonbacterial meningitis","volume":"95","author":"Wei","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cca.2019.06.010_bb0165","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jpeds.2009.06.037","article-title":"Serum procalcitonin for prediction of renal parenchymal involvement in children with urinary tract infections: a meta-analysis of prospective clinical studies","volume":"155","author":"Mantadakis","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.cca.2019.06.010_bb0170","article-title":"A clinical prediction rule to identify febrile infants 60 days and younger at low risk for serious bacterial infections","author":"Kuppermann","year":"2019","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.cca.2019.06.010_bb0175","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/SHK.0000000000000305","article-title":"Procalcitonin levels in survivors and nonsurvivors of sepsis: systematic review and meta-analysis","volume":"43","author":"Arora","year":"2015","journal-title":"Shock"},{"key":"10.1016\/j.cca.2019.06.010_bb0180","article-title":"Prognostic value of procalcitonin in adult patients with sepsis: a systematic review and meta-analysis","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2019.06.010_bb0185","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/CCM.0000000000002321","article-title":"Serial procalcitonin predicts mortality in severe sepsis patients: results from the multicenter procalcitonin MOnitoring SEpsis (MOSES) study","volume":"45","author":"Schuetz","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4414\/smw.2009.12584","article-title":"Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections - hope for hype","volume":"139","author":"Schuetz","year":"2009","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.cca.2019.06.010_bb0195","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0140-6736(04)15591-8","article-title":"Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial","volume":"363","author":"Christ-Crain","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2019.06.010_bb0200","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.cca.2019.06.010_bb0205","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections (eview)","author":"Schuetz","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cca.2019.06.010_bb0210","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/jama.2018.0852","article-title":"Procalcitonin testing to guide antibiotic therapy in acute upper and lower respiratory tract infections","volume":"319","author":"Schuetz","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cca.2019.06.010_bb0215","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cca.2019.06.010_bb0220","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archinternmed.2012.770","article-title":"Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in \u201creal life\u201d","volume":"172","author":"Albrich","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0225","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/archinte.168.18.2000","article-title":"Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care","volume":"168","author":"Briel","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0230","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.00163309","article-title":"Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection","volume":"36","author":"Burkhardt","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.cca.2019.06.010_bb0235","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1515\/cclm-2017-0252","article-title":"Effects of procalcitonin testing on antibiotic use and clinical outcomes in patients with upper respiratory tract infections. An individual patient data meta-analysis","volume":"56","author":"Odermatt","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0240","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/viru.1.2.10488","article-title":"Guidance of antibiotic therapy with procalcitonin in lower respiratory tract infections: insights into the ProHOSP study","volume":"1","author":"Schuetz","year":"2010","journal-title":"Virulence"},{"key":"10.1016\/j.cca.2019.06.010_bb0245","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0140-6736(09)61879-1","article-title":"Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial","volume":"375","author":"Bouadma","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2019.06.010_bb0250","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1097\/CCM.0b013e31821201a5","article-title":"Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation","volume":"39","author":"Heyland","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijantimicag.2007.10.015","article-title":"Daily cost of antimicrobial therapy in patients with intensive care unit-acquired, laboratory-confirmed bloodstream infection","volume":"31","author":"Vandijck","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.cca.2019.06.010_bb0260","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.diagmicrobio.2013.03.027","article-title":"Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting","volume":"76","author":"Deliberato","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.cca.2019.06.010_bb0265","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1373\/clinchem.2017.272294","article-title":"The role of procalcitonin in diagnosis of sepsis and antibiotic stewardship: opportunities and challenges","volume":"63","author":"Fung","year":"2017","journal-title":"Clin. Chem."},{"issue":"v-xxv","key":"10.1016\/j.cca.2019.06.010_bb0270","first-page":"1","article-title":"Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis","volume":"19","author":"Westwood","year":"2015","journal-title":"Health Technol. Assess."},{"issue":"Suppl. 242","key":"10.1016\/j.cca.2019.06.010_bb0275","first-page":"66","article-title":"Is this biomarker ready for the prime time?","volume":"70","author":"Cardiac","year":"2010","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2019.06.010_bb0280","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1097\/CCM.0b013e31821e8791","article-title":"Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial","volume":"39","author":"Jensen","year":"2011","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0285","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1802670","article-title":"Procalcitonin-guided use of antibiotics for lower respiratory tract infection","volume":"379","author":"Huang","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2019.06.010_bb0290","author":"National Institute for Health and Care Excellence (NICE) guidance"},{"key":"10.1016\/j.cca.2019.06.010_bb0295","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.clinbiochem.2017.03.002","article-title":"The role of laboratory in ensuring appropriate test requests","volume":"50","author":"Ferraro","year":"2017","journal-title":"Clin. Biochem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119319023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119319023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:47:45Z","timestamp":1757861265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119319023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":59,"alternative-id":["S0009898119319023"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.06.010","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Procalcitonin: Between evidence and critical issues","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}